In addition, the systemic administration of miR-29b potently suppresses tumor vascularization by targeting VEGF-A, resulting in the dramatic suppression of tumor growth without toxicity, indicating that this single miRNA could be used as an efficient anti-cancer therapeutic agent [39]. This evidence concerns the gene VEGFA and cancer.